Browse Studies — Arctuva

Phase 2

A Phase 2 Pilot Study of the Role of Sequential Immune Checkpoint Inhibitor Toripalimab and Chemotherapy Paclitaxel in Patients With HNSCC and ECOG Performance Score of 2

The goal of this clinical trial is to learn if the drug Toripalimab can prime the tumor to optimize response to Paclitaxel in HNSCC patients with a decrease pe…

Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)

Estimated

~$10 – $7,500

Barbara Ann Karmanos Cancer InstituteNCT07796126

Phase 1

Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

The goal of this Phase 1 clinical trial is to evaluate the safety and feasibility of nivolumab-IRDye800CW (nivo800) as a molecular imaging agent in adults with…

HnsccHead and NeckSquamous Cell Cancer+8 more

Estimated

~$10 – $6,250

Vanderbilt-Ingram Cancer CenterNCT07460765

Phase 2

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

This study is for adult patients with head and neck cancer who are at risk of recurrence. The purpose of this study is to evaluate whether the use of Indocyani…

Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)Margin Assessment

Estimated

~$10 – $6,250

Medical University of South CarolinaNCT07149207

Tumor-informed ctDNA Testing for Minimal Residual Disease Monitoring Following Curative-intent Treatment of Squamous Cell Carcinoma of the Head and Neck.

This is a single-center, non-interventional, observational study that evaluates the correlation of circulating tumor DNA (ctDNA) testing to cancer relapse for …

Squamous Cell Carcinoma of Head and NeckSquamous Cell Carcinoma Head and Neck Cancer (HNSCC)Squamous Cell Carcinoma of Skin+1 more

Estimated

~$10 – $675

University of California, San FranciscoNCT06606028